🇺🇸 FDA
Patent

US 10155796

Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5

granted A61KA61K31/495A61K38/00

Quick answer

US patent 10155796 (Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5) held by The Regents of the University of California expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/495, A61K38/00, A61K38/1709, A61P